1. bookVolumen 59 (2009): Edición 1 (March 2009)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents

Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

F. E. Simons and K. J. Simons, The pharmacology and use of H1-receptor-antagonist drugs, N. Engl. J. Med. 330 (1994) 1663-1670; DOI: 10.1056/NEJM199406093302307.10.1056/NEJM199406093302307Search in Google Scholar

H. Van der Goot, A. Bast and H. Timmerman, Structural Requirements for Histamine H2 Agonists and H2 Antagonists, in Histamine and Histamine Antagonists (Ed. B. Uvniis), Springer, Berlin 1991, pp. 573-748.10.1007/978-3-642-75840-9_27Search in Google Scholar

A. A. Carr and D. R. Meyer, Synthesis of terfenadine, Arzneimittelforsch. 32 (1982) 1157-1159.Search in Google Scholar

R. J. Hopp, A. Bewtra, N. M. Nair and R. G. Townley, The effect of age on methacholine response, J. Allergy Clin. Immunol. 76 (1985) 609-613; DOI: 10.1016/0091-6749(85)90783-3.10.1016/0091-6749(85)90783-3Search in Google Scholar

N. Chairungsrilerd, K. Furukawa, T. Ohta, S. Nozoe and Y. Ohizumi, Pharmacological properties of alpha-mangostin, a novel histamine H1 receptor antagonist, Eur. J. Pharmacol. 314 (1996) 351-356.10.1016/S0014-2999(96)00562-6Search in Google Scholar

F. Estelle, R. Simons and K. Simons, Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy, Clin. Pharmacokin. 21 (1991) 372-393.10.2165/00003088-199121050-000051685361Search in Google Scholar

H. Renner, S. Schnitzler, V. Hagen, K. Kottke and H. Kuehmstedt, Antianaphylactic effects of 2-hydrazino-3-arylquinazol-4-ones and 4-aryl-5-oxo-4,5-dihydro-sym-triazolo[4,3-a]quinazolines, Pharmazie 35 (1980) 801-802.Search in Google Scholar

V. Alagarsamy, R. Venkatesaperumal, S. Vijayakumar, T. Angayarkanni, P. Pounammal, S. Senthilganesh and S. Kandeeban, Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers, Pharmazie 57 (2002) 306-307.Search in Google Scholar

V. Alagarsamy, Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers, Pharmazie 59 (2004) 753-755.Search in Google Scholar

J. Van Wauwe, F. Awouters, C. J. E. Niemegeers, F. Janssens, J. M. Van Nueten and P. A. Janssen, In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound, J. Arch. Pharmacodyn. Ther. 251 (1981) 39-51.Search in Google Scholar

G. B. Shah and N. S. Parmar, Antiasthmatic property of polyherbal preparation E-721 B, Phytother Res. 17 (2003) 1092-1097; DOI: 10.1002/ptr.1344.10.1002/ptr.134414595594Search in Google Scholar

B. N. Suhagia, M. T. Chhabria and A. G. Makwana, Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists, J. Enzyme Inhib. Med. Chem. 21 (2006) 681-691.10.1080/1475636060085110417252940Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo